Info

The Create Your Own Life Show

The Create Your Own Life podcast covers some of the most important and sometimes controversial topics. We talk about things that matter, we're free thinkers in search of becoming extraordinary. We have conversations every Tuesday and Thursday to help understand the world around you better, to help take control and create your own life.
RSS Feed Subscribe in Apple Podcasts
The Create Your Own Life Show
2022
December
November
October
September
August
July
June
May
April
March
February
January


2021
December
November
October
September
August
July
June
May
April
March
February
January


2020
December
November
October
September
August
July
June
May
April
March
February
January


2019
December
November
October
September
August
July
June
May
April
March
February
January


2018
December
November
October
September
August
July
June
May
April
March
February
January


2017
December
November
October
September
August
July
June
May
April
March
February
January


2016
December
November
October
September
August
July
June
May
April
March
February
January


2015
December
November


Categories

All Episodes
Archives
Categories
Now displaying: Page 1
Oct 31, 2017

Mirza Cifric is the Co-Founder and Chief Executive Officer or Veritas Genetics, one of the most innovating companies in the biotech industry. Mirza is a life sciences entrepreneur. Formerly CEO AbVitro, Head of Corp. Dev. FORMA Therapeutics.

 

About Veritas Genetics:

Veritas is a passionate and dynamic group of scientists, engineers, genetic counselors, business folk, and designers. Their goal: empower people to live healthier, longer.

But, their story began in the 1970s with a young student passionate about one thing, DNA. George Church's work set in motion countless genetic discoveries, including the Human Genome Project, the first initiative to map all genes in the human genome.

George, along with a group of visionaries and scientists, including leaders from Harvard Medical School's Personal Genome Project, co-founded Veritas.

0 Comments
Adding comments is not available at this time.